The G-protein coupled receptors (GPCRs) market is set to witness accelerated growth over the next decade. Advancements in molecular research and protein studies have been at the forefront of market maturity. Furthermore, cellular analysis is also an important application of these proteins. Medical researchers pay immense attention on the study of the cell membrane, and other parts of the cell. Furthermore, cellular responses of the body can help in diagnosing and detecting a number of diseases and disorders. Therefore, the global G-protein coupled receptors (GPCRs) market is expected to attract voluminous revenues in the years to follow. The large protein family that falls under this class of receptors has become a matter of discussion across the medical fraternity.

Study of various pathways for signal transduction involves the use of G-protein coupled receptors (GPCRs). Furthermore, these protein receptors help in conducting cellular research, and in studying the function of the cell membrane. The field of medical research has become the epicentre of advancements within healthcare. New lines of treatments can be conceptualised through intensive research across medical sciences. Besides, rising incidence of bone diseases and disorders has compelled the medical industry to improve its functional dynamics. On account of the aforementioned factors, it is safe to prognosticate the inflow of fresh revenues into the global G-protein coupled receptors (GPCRs) market.

Advancements in Physiology to Drive Market Demand

Application of G-protein coupled receptors (GPCRs) in the domain of physiology has emerged as an important dynamic of market growth. Regulation of the immune system involves the use of protein receptors. Furthermore, control of inflammation in the human body at the hands of chemokine receptors shall help in driving market demand. The vendors in the global G-protein coupled receptors (GPCRs) market are expected to capitalise on the gaps existing in medical research. The ability to meet the requirements of the research fraternity shall play a defining role in driving market demand.

Treatment of tumours is a defining metric to gauge the effectiveness of the medical fraternity. Moreover, growth and metastasis of tumours needs to be decoded in order to develop effective treatment lines. This factor, coupled with advancements in protein structure analysis, shall fetch fresh revenues for the market players. Recognition of hormones and processing of odours are amongst other key applications of G-protein coupled receptors (GPCRs). Scientists across the globe are making ardent efforts to discover new applications of G-protein coupled receptors (GPCRs). The medical fraternity shall contribute towards the market growth and maturity in the coming times. The swiftness of these receptors in terms of activation is amongst their most splendid attributes.

Focus on Treating Cardiovascular and Immune Diseases

On the basis of therapeutic areas, the global G-protein coupled receptors (GPCRs) market can be segmented into central nervous system, cardiovascular system, immune system, respiratory system, oncology, and reproductive system. The uncontested need for improved treatment lines in each of the aforementioned areas shall aid market growth. Oncological research has become an important area of research within medicine. Moreover, GPCRs hold tremendous relevance in treating disorders related to the respiratory system and central nervous system. Advancements in gynaecology shall also unfurl fresh opportunities for growth and advancement within the global market.

North America Market to Expand with Advancements in Oncology

On the basis of geography, the global G-protein coupled receptors (GPCRs) market can be segmented into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. The North America market is slated to tread along a lucrative track in the years to follow. Advancements in oncological research across the US has created tremendous opportunities for regional market growth.

Some of the leading vendors in the global G-protein coupled receptors (GPCRs) market are Thermo Fisher Scientific, Inc., Becton, and Dickinson and Company/

G-protein-coupled receptors (GPCRs) are widely regarded as the most diverse and largest group of membrane receptors in organisms called eukaryotes. These receptors play the role of an inbox for messages that come in the form of proteins, sugars, lipids, peptides, and light energy. These messages tell the cells about the absence or presence of life-sustaining nutrients and lights in their surroundings. These cells also convey the information that is sent by various other cells. The global g-protein coupled receptors (GPCRS) market gathers momentum from growing prevalence of various lifestyle diseases such as diabetes.

G-protein-coupled receptors play an important role in an extremely wide array of functions in the body of a human being. The augmented understanding about these receptors has played a significant role in the modern day medicine, which is estimated to drive the development of the global g-protein coupled receptors (GPCRS) market in years to come. As a matter of fact, an estimations by researchers say that between one-third and one-half of all the drugs that are marketed act through its binding with G-protein-coupled receptors.

High Prevalence of Lifestyle Diseases Drive Growth of the Market

A substantial rise in the incidences of various lifestyle-related disorders such as respiratory issues, cardiovascular infections, and breast cancer is driving the augmented need for the development of better and novel treatment methods. G-protein coupled receptors have proven to be highly useful in the innovative work for invention of newer substances of medication. In addition, augmented funding by governments is likely to act in favor the growth of the global g-protein coupled receptors (GPCRS) market over the tenure of assessment. Governments are increasingly funding in research on subjects like high-throughput screening methods, sedate targets, orphan drug receptors, and biosensors.

Utilization of G-protein-coupled receptors assays in cancer research produces substantial amount of revenue. Numerous research projects have proved that the G-protein-coupled receptors activity exhibits the following conditions in cancer patients

  • drug resistance
  • angiogenesis
  • tumor proliferation
  • metastasis
  • invasiveness

North America is likely to come up as one of the promising regions in the global g-protein coupled receptors (GPCRS) market over the a in the field of cancer research.

This report on G-protein coupled receptors (GPCRs) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies engaged in manufacturing and commercialization of GPCR assays, cell lines, and consumables and entrants that are planning to invest in the GPCRs market. This report comprises an elaborate executive summary, which includes a market snapshot providing overall information of various segments and sub-segments included in the study scope. This section also provides overall information and data analysis of the global GPCRs market with respect to the leading market segments based on types of products, applications and geographic regions.

 
The global GPCRs market has been segmented based on of assay type, therapeutic area, and geography. Based on assay type, the GPCRs market has been categorized into six major segments: cAMP assays, calcium level detection assays, GTPγS binding assays, reporter gene assays, receptor internalization assays, and cGMP assays. The market for these segments has been extensively analyzed based on of their effectiveness, usefulness, sales, and geographic presence. Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.
 
In terms of therapeutic areas, the market has been segmented into seven categories: cardiovascular system, central nervous system (CNS), respiratory system, immune system, reproductive system, oncology, and others (abdominal, urinary, orthopedics, etc.). Market revenue in terms of USD million for the period between 2012 and 2022 along with the compound annual growth rate (CAGR %) from 2014 to 2022 are provided for all the segments, considering 2013 as the base year.
 
The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that have strong impact on the GPCRs market currently and could influence the market in future as well. The market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. Porter’s Five Forces analysis is also explained in this section to understand the GPCRs market considering different parameters that have an impact on the sustainability of the companies operating in the GPCRs market. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.
 
Geographically, the GPCRs market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). Major geographic regions have been further divided into major national markets, viz. North America (the U.S. and Canada), Europe (Germany, the U.K., France, and Rest of Europe), and Asia Pacific (China, Japan, India, and Rest of Asia Pacific). Moreover, Rest of the World has been further subdivided into three regions: Latin America, the Middle East, and Africa. Market revenue in terms of USD million for the period between 2012 and 2022 along with the CAGR % from 2014 to 2022 are provided for all the regional and national markets considering 2013 as the base year.
 
The recommendations section included in the report would assist existing market players in expanding their market shares and new companies in establishing their presence in the global market. The report also profiles major players in the GPCRs market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Thermo Fisher Scientific, Inc., EMD (Merck) Millipore, Becton, Dickinson and Company, PerkinElmer, Inc., Cisbio Bioassays, Enzo Life Sciences, Inc., DiscoveRx Corporation, Sigma-Aldrich Corporation, QIAGEN N.V., Promega Corporation, Abcam plc, and HD Biosciences Co. Ltd.
 
The global GPCRs market is segmented as follows:
 
GPCRs Market, by Assay Type
  • Calcium Level Detection Assays 
  • GTPγS Binding Assays 
  • cGMP Assays
  • Reporter Gene Assays 
  • Receptor Internalization Assay 
  • cAMP Assays 
GPCRs Market, by Therapeutic Area
  • Cardiovascular System
  • Central Nervous System
  • Respiratory System
  • Immune System
  • Reproductive System
  • Oncology
  • Others
GPCRs Market, by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America
    • Middle East
    • Africa.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

G Protein Coupled Receptors Market

Buy Now